Erlotinib is a chemotherapeutic drug given to lung cancer patients with an EGFR mutation. Erlotinib. Chemotherapeutic drug given to lung cancer patients with "EGFR" mutation.
El erlotinib es un fármaco quimioterapéutico administrado a pacientes con cáncer de pulmón con una mutación del EGFR. Erlotinib. Medicamento quimioterapéutico administrado a pacientes con cáncer de pulmón con mutación del "EGFR".
| Front | Chemotherapeutic drug given to lung cancer patients with an EGFR mutation. |
|---|---|
| Back | Erlotinib. |
Learn with these flashcards. Click next, previous, or up to navigate to more flashcards for this subject.
Next card: Chemotherapeutic drug lung cancer patients alk translocation crizotinib
Previous card: Egfr mutations common asian females non-smokers
Up to card list: Chapter 9: Respiratory Tract Pathology